Challenge of Chronic Pain Conference

1-3 March 2017

Wellcome Genome Campus, Hinxton, Cambridge

The meeting discussed recent discoveries and current challenges in pain research, with a focus on translating basic research insights into new therapies. The programme highlighted advances in our understanding of peripheral and central pain mechanisms, pathways and processes. We explored the clinical landscape of chronic pain and pain syndromes, the innovative approaches to target validation in animal and human studies, and their translation into novel therapeutic interventions. This meeting was aimed at scientists, clinicians, and those working in industry or on translational research, interested in understanding chronic pain and improving the process from mechanism to therapy. Visit the conference website for current information.

Topics:

• Chronic pain: the clinical landscape and translational horizons
• CNS processing in acute and chronic pain
• The genetics of pain
• Cellular biology of pain
• Peripheral pain molecules
• Drug discovery and development
• Neuro-immune interactions
• Imaging

Scientific programme committee:

• Jon Levine (University of California, San Francisco, USA)            
• Stephen McMahon (King's College London, UK)              
• Cheryl Stucky (Medical College of Wisconsin, USA)            
• Fan Wang (Duke University, USA)          
• John Wood (University College London, UK)         

Keynote speakers

• Howard Fields (University of California, San Francisco, USA)
• Nick Franks (Imperial College London, UK)

Confirmed speakers

• Robert Brownstone (University College London, UK)
• Cathy Bushnell (National Institutes of Health, USA)
• James Cox (University College London, UK)
• Yves De Koninck (Research Centre of the Québec Mental Health Institute, Canada)
• Nanna Brix Finnerup (Danish Pain Research Center, Denmark)
• Robert Gereau (Washington University School of Medicine, USA)
• Peter Goadsby (King's College London, UK)
• Sten Linnarsson (Karolinska Institute, Sweden)
• Sarah Ross (University of Pittsburgh, USA)
• Dinah Sah (Voyager Therapeutics, USA)
• Camilla Svensson (Karolinska Institute, Sweden)
• Andrew Todd (University of Glasgow, UK)
• Tor Wager (University of Colorado, USA)
• Steve Waxman (Yale School of Medicine, USA)
• Xu Zhang (Institute of Neuroscience, China)